Results for this period
Interim period (second quarter)1 April 2026–30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in Thousands of yen).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Expansion into new customer segments in response to demand for more sophisticated and efficient corporate health management operations, an increase in the number of service users, deeper transactions with existing customers, development of new customers, price revisions, the launch of new products and improved operational efficiency
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026–30 September 2026 |
| Net Sales | 8,998 Millions of yen |
| Operating profit | 829 Millions of yen |
| Ordinary income | 853 Millions of yen |
| Profit attributable to owners of the parent | 632 Millions of yen |
| Net income per share | ¥50.73 |
| Equity ratio | End of the current fiscal period 50.3 / End of previous period 59.9 |
| Total assets | 11,995 Millions of yen |
| Net assets | 6,039 Millions of yen |
| Cash flows from operating activities | 877,295 Thousands of yen |
| Cash flows from investing activities | -232,728 Thousands of yen |
| Cash flows from financing activities | -608,522 Thousands of yen |
| Cash and cash equivalents at end of period | 5,296,193 Thousands of yen |
| Full-year earnings forecast | Net Sales 17,500 Millions of yen (YoY +18.4%) / Operating profit 1,600 Millions of yen (YoY +34.9%) / Ordinary income 1,555 Millions of yen (YoY +33.6%) / Net income 1,150 Millions of yen (YoY +40.0%) |
| Annual Dividend Forecast | 34.4 Yen → 40 Yen（+16.3%） |
| Segment revenue | Solutions business 7,169,335 Thousands of yen, Cloud Business 1,828,933 Thousands of yen, Other Business 576 Thousands of yen |
| Segment profit | Solutions business 115,409 Thousands of yen, Cloud Business 717,339 Thousands of yen, Other Business -3,442 Thousands of yen |
| Depreciation and amortization | 163,916 Thousands of yen |
| Breakdown of extraordinary income (loss) | Extraordinary income Not disclosed / Extraordinary loss Loss on disposal of fixed assets 8,343 Thousands of yen |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement None |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name None |
| Material subsequent events | At a meeting of the Board of Directors held on 27 October 2026, the Company resolved to acquire 32.86% of the issued shares of T-PEC Co., Ltd. and make it an equity-method affiliate. The scheduled acquisition date is 30 November 2026, and the approximate acquisition price is ¥1,273 million. |
| Availability of Supplementary Financial Results Materials | Available |
| Availability of Financial Results Briefing | Held (for institutional investors and analysts) |
| Issued Shares at Period-End | 12,463,400 |
| Treasury Shares at Period-End | 0 |
| Factors Behind Changes in Business Performance | Expansion into new customer segments in response to demand for more sophisticated and efficient corporate health management operations, an increase in the number of service users, deeper transactions with existing customers, development of new customers, price revisions, the launch of new products and improved operational efficiency |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company proceeded with expansion into new customer segments, including the market for mid-sized and small companies, in response to demand for more sophisticated and efficient corporate health management operations. It also increased the number of service users, deepened transactions with existing customers, developed new customers, revised prices, launched new products and improved operational efficiency.